Abstract
The last two decades have seen a concerted international effort at developing, implementing and evaluating early intervention in psychosis services (EIS). The impetus for this is the well-documented association between a longer duration of untreated psychosis (DUP) and a poorer outcome, the accumulation of disability preceding the emergence of frank psychotic symptoms and the emerging evidence of progressive neurobiological changes in the pre-psychotic and early stages of first-episode psychosis (FEP). Several robust clinical trials have confirmed the clinical and cost-effectiveness of specialist EIS in improving medium-term outcomes and functioning as compared to standard care. Almost all the work in this area, both clinical and academic, has been done in developed countries. The “at-risk” population for the emergence of psychosis—late adolescence and early adulthood—predominantly lives in countries such as India where DUP is much longer and service provision for psychosis is scarce, concentrated mainly in urban areas and a few large psychiatric institutions. This chapter will summarise the clinical and research foundations of the early intervention paradigm, review the evidence for the effectiveness of EIS in improving outcomes in early psychosis and discuss the possible application of the EIS model to the Indian setting. It will explore the training and resource constraints in implementing such a model in India, suggest a public health approach for screening, identifying and treating early psychosis within these constraints, and discuss EIS effectiveness and implementation research in an Indian EIS setting.
S.P. Singh, Professor and Head of Division
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bechdolf, A., Knost, B., et al. (2004). A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica, 110(1), 21–28.
Berger, G. E., Wood, S. J., et al. (2008). Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology, 33(10), 2467–2473.
Bertelsen, M., Jeppesen, P., et al. (2007). Suicidal behaviour and mortality in first-episode psychosis: The OPUS trial. British Journal of Psychiatry, 51(Suppl), s140–s146.
Bertelsen, M., Jeppesen, P., et al. (2008). Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: The OPUS trial. Archives of General Psychiatry, 65(7), 762–771.
Birchwood, M., Todd, P., et al. (1998). Early intervention in psychosis. The critical period hypothesis. British Journal of Psychiatry, 172(Suppl 33), 53–59.
Burns, J. K., Jhazbhay, K., et al. (2011). Causal attributions, pathway to care and clinical features of first-episode psychosis: A South African perspective. International Journal of Social Psychiatry, 57(5), 538–545.
Cameron, D. E. (1938). Early schizophrenia. American Journal of Psychiatry, 95(3), 567–582.
Chiliza, B., Asmal, L., et al. (2012). Early intervention in schizophrenia in developing countries: Focus on duration of untreated psychosis and remission as a treatment goal. International Review of Psychiatry, 24(5), 483–488.
Chisholm, D., Flisher, A. J., et al. (2007). Scale up services for mental disorders: A call for action. Lancet, 370(9594), 1241–1252.
Correll, C. U., Hauser, M., et al. (2010). Research in people with psychosis risk syndrome: A review of the current evidence and future directions. Journal of Child Psychology and Psychiatry, 51(4), 390–431.
Craig, T. K., Garety, P., et al. (2004). The Lambeth Early Onset (LEO) Team: Randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ, 329(7474), 1067.
Farooq, S. (2013). Early intervention for psychosis in low-and middle-income countries needs a public health approach. British Journal of Psychiatry, 202(3), 168–169.
Farooq, S., Large, M., et al. (2009a). Early intervention in psychosis in developing countries: Evidence and action. World Psychiatry, 8(2), 123.
Farooq, S., Large, M., et al. (2009b). The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: A systematic review and meta analysis. Schizophrenia Research, 109(1–3), 15–23.
Friis, S., Melle, I., et al. (2004). Does duration of untreated psychosis bias study samples of first-episode psychosis? Acta Psychiatrica Scandinavica, 110(4), 286–291.
Friis, S., Vaglum, P., et al. (2005). Effect of an early detection programme on duration of untreated psychosis: Part of the Scandinavian TIPS study. British Journal of Psychiatry, 48(Suppl), s29–s32.
Gafoor, R., Nitsch, D., et al. (2010). Effect of early intervention on 5-year outcome in non-affective psychosis. British Journal of Psychiatry, 196(5), 372–376.
Geller, J. L. (2000). The last half-century of psychiatric services as reflected in psychiatric services. Psychiatric Services, 51(1), 41–67.
Hafner, H., Riecher-Rossler, A., et al. (1992). IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research, 6(3), 209–223.
Harrison, G., Hopper, K., et al. (2001). Recovery from psychotic illness: A 15-and 25-year international follow-up study. British Journal of Psychiatry, 178, 506–517.
Johannessen, J. O., Larsen, T. K., et al. (2005). Pathways to care for first-episode psychosis in an early detection healthcare sector: Part of the Scandinavian TIPS study. British Journal of Psychiatry, 187(Suppl 48), s24–s28.
Johnstone, E. C., Crow, T. J., et al. (1986). The Northwick park study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. British Journal of Psychiatry, 148, 115–120.
Killackey, E., Yung, A. R., et al. (2007). Early psychosis: Where we’ve been, where we still have to go. Epidemiologia Psichiatria Sociale, 16(2), 102–108.
Lamers, L. M., McDonnell, J., et al. (2006). The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15(10), 1121–1132.
Large, M., Farooq, S., et al. (2008a). Relationship between gross domestic product and duration of untreated psychosis in low-and middle-income countries. British Journal of Psychiatry, 193(4), 272–278.
Large, M., Nielssen, O., et al. (2008b). Measurement and reporting of the duration of untreated psychosis. Early Intervention Psychiatry, 2(4), 201–211.
Lloyd-Evans, B., Crosby, M., et al. (2011). Initiatives to shorten duration of untreated psychosis: Systematic review. British Journal of Psychiatry, 198(4), 256–263.
Malhotra, S., Chakrabarti, S., et al. (2013). Telepsychiatry: Promise, potential, and challenges. Indian Journal of Psychiatry, 55(1), 3–11.
Malla, A. K., Bodnar, M., et al. (2011). Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophrenia Research, 125(1), 13–20.
Marshall, M., Lewis, S., et al. (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Archives of General Psychiatry, 62(9), 975–983.
McCrone, P., & Knapp, M. (2007). Economic evaluation of early intervention services. British Journal of Psychiatry, 191(51), s19–s22.
McGlashan, T. H., Miller, T. J., et al. (2001). Pre-onset detection and intervention research in schizophrenia psychoses: Current estimates of benefit and risk. Schizophrenia Bulletin, 27(4), 563–570.
McGlashan, T. H., Zipursky, R. B., et al. (2006). Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163(5), 790–799.
McGorry, P. D. (1998). “A stitch in time” … the scope for preventive strategies in early psychosis. European Archives of Psychiatry and Clinical Neuroscience, 248(1), 22–31.
McGorry, P. D. (2000). Evaluating the importance of reducing the duration of untreated psychosis. Australian New Zealand Journal of Psychiatry, 34(s2), S145–S149.
McGorry, P. D., Yung, A. R., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59(10), 921–928.
McGorry, P. D., Yung, A. R., et al. (2003). The “close-in” or ultra high-risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin, 29(4), 771–790.
Melle, I., Haahr, U., et al. (2005). Reducing the duration of untreated first-episode psychosis—effects on baseline social functioning and quality of life. Acta Psychiatrica Scandinavica, 112(6), 469–473.
Morrison, A. P., French, P., et al. (2004). Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. British Journal of Psychiatry, 185, 291–297.
Naqvi, H. A., Hussain, S., et al. (2009). Pathways to care: Duration of untreated psychosis from Karachi, Pakistan. PLoS ONE, 4(10), e7409.
Nordentoft, M., Petersen, L., et al. (2006). OPUS: A randomised multicenter trial of integrated versus standard treatment for patients with a first-episode psychosis--secondary publication. Ugeskrift for Laeger, 168(4), 381–384.
Norman, R. M., Townsend, L., et al. (2001). Duration of untreated psychosis and cognitive functioning in first-episode patients. British Journal of Psychiatry, 179, 340–345.
Patel, V., Garrison, P., et al. (2008). The Lancet’s series on global mental health: 1 year on. Lancet, 372(9646), 1354–1357.
Perkins, D. O., Gu, H., et al. (2005). Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. American Journal of Psychiatry, 162(10), 1785–1804.
Rabiner, C. J., Wegner, J. T., et al. (1986). Outcome study of first-episode psychosis. I: Relapse rates after 1 year. American Journal of Psychiatry, 143(9), 1155–1158.
Rangaswamy, T., Mangala, R., et al. (2012). Early intervention for first-episode psychosis in India. East Asian Archives Psychiatry, 22(3), 94–99.
Rethink (2002). Reaching people early. London: Rethink.
Ruhrmann, S., Paruch, J., et al. (2008). Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatrica Scandinavica, 117(5), 357–368.
Saxena, S., Lora, A., et al. (2011). Mental health services in 42 low-and middle-income countries: A WHO-AIMS cross-national analysis. Psychiatric Services, 62(2), 123–125.
Saxena, S., & Sharan, P. (2004). Supporting mental health research publications from low-and middle-income countries. Revista Brasileria Psiquiatria, 26(2), 73–74.
Singh, S. P. (2007). Outcome measures in early psychosis; Relevance of duration of untreated psychosis. British Journal of Psychiatry, 191(50), s58–s63.
Singh, S. P. (2010). Early intervention in psychosis. British Journal of Psychiatry, 196(5), 343–345.
Singh, S. P., Cooper, J. E., et al. (2005). Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS). Schizophrenia Research, 80(1), 117–130.
Singh, S. P., Croudace, T., et al. (2000). Three-year outcome of first-episode psychoses in an established community psychiatric service. British Journal of Psychiatry, 176, 210–216.
Singh, S. P., Wright, C., et al. (2003). Developing early intervention services in the NHS: A survey to guide workforce and training needs. Psychiatric Bulletin, 27(7), 254–258.
Stafford, M. R., Jackson, H., et al. (2013). Early interventions to prevent psychosis: Systematic review and meta-analysis. BMJ, 346, f185.
Sullivan, P. W., & Ghushchyan, V. (2006). Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Medical Decision Making, 26(4), 401–409.
Singh, S. P., & Grange, T. (2006). Measuring pathways to care in first-episode psychosis: a systematic review. Schizophrenia Research, 81(1):75–82.
Thara, R. (2012). Using mobile telepsychiatry to close the mental health gap. Current Psychiatry Reports, 14(3), 167–168.
Thara, R., John, S., et al. (2008). Telepsychiatry in Chennai, India: The SCARF experience. Behavioral Sciences and the Law, 26(3), 315–322.
Thara, R., & Sujit, J. (2013). Mobile telepsychiatry in India. World Psychiatry, 12(1), 84.
Tirupati, N. S., Rangaswamy, T., et al. (2004). Duration of untreated psychosis and treatment outcome in schizophrenia patients untreated for many years. Australian and New Zealand Journal of Psychiatry, 38(5), 339–343.
Valmaggia, L. R., McCrone, P., et al. (2009). Economic impact of early intervention in people at high risk of psychosis. Psychological Medicine, 39(10), 1617–1626.
Verdoux, H., Liraud, F., et al. (2001). Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophrenia Research, 49(3), 231–241.
Warner, R. (2002). Early intervention in schizophrenia: A critique. Epidemiologia Psichiatria Sociale, 11(4), 248–255.
Warner, R. (2005). Problems with early and very early intervention in psychosis. British Journal of Psychiatry, 187(Suppl 48), s104–s107.
Wiersma, D., Nienhuis, F. J., et al. (1998). Natural course of schizophrenic disorders: A 15-year followup of a Dutch incidence cohort. Schizophrenia Bulletin, 24(1), 75–85.
Wyatt, R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin, 17(2), 325–351.
Yung, A. R., Nelson, B., et al. (2008). Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophrenia Research, 105(1–3), 10–17.
Yung, A. R., Phillips, L. J., et al. (1998). Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry, 172(33), 14–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer India
About this chapter
Cite this chapter
Singh, S.P. (2015). Early Intervention in the Indian Context. In: Malhotra, S., Chakrabarti, S. (eds) Developments in Psychiatry in India. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1674-2_7
Download citation
DOI: https://doi.org/10.1007/978-81-322-1674-2_7
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1673-5
Online ISBN: 978-81-322-1674-2
eBook Packages: MedicineMedicine (R0)